Guillain-Barré syndrome: update on immunobiology and treatment. - Wikidata - wikimedia - TriplyDB

Guillain-Barré syndrome: update on immunobiology and treatment.

Guillain-Barré syndrome: update on immunobiology and treatment.

http://www.wikidata.org/entity/Q37600859

about

From Lithium Intoxication to Lung Cancer: A Woman's Diagnostic Journey.Guillain-Barré syndrome following sepsis after stereotactic aspiration for spontaneous pontine hemorrhage.

P2860

Q38568260-CE03FFAF-6A8F-43AC-9EA2-85457F0514F4 Q48832240-90574AA6-29A5-486C-9D11-960A7978418E

P2860

Guillain-Barré syndrome: update on immunobiology and treatment.

http://www.wikidata.org/entity/Q37600859

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Guillain-Barré syndrome: update on immunobiology and treatment.

@en

Guillain-Barré syndrome: update on immunobiology and treatment.

@nl

type

label

Guillain-Barré syndrome: update on immunobiology and treatment.

@en

Guillain-Barré syndrome: update on immunobiology and treatment.

@nl

prefLabel

Guillain-Barré syndrome: update on immunobiology and treatment.

@en

Guillain-Barré syndrome: update on immunobiology and treatment.

@nl

P1433

Q37600859-63154C5B-832F-491E-A22C-1BE43E2CF8D2

P1476

Q37600859-A4A373EB-7533-489D-B870-04C9C07270A2

P2093

Q37600859-35397EED-D6C4-47F5-A852-214F29F4BA47

P2860

Q37600859-02D8F773-6A2E-4C3E-B948-41CE72660BFF

Q37600859-0357709B-665E-4DD7-8CD9-0962D0391F8D

Q37600859-0530DE68-AA79-49B8-A922-852E775F1039

Q37600859-067CBB8F-DB8B-4D2A-92C6-1D3BC1C6EA23

Q37600859-0885D032-3B88-4B32-8115-16F7C67DC0CB

Q37600859-0A33B0A8-6FCE-4F21-81C7-73D2AC24DC80

Q37600859-0A8C74CB-D525-438C-A919-D95A096176C3

Q37600859-0FA9A9BF-5152-4DFE-8028-7ADBFB10F4D8

Q37600859-1C9ECE3E-7D75-4A62-A4F5-996277173206

Q37600859-1E64E9E7-D23A-47EF-8441-5E1742D71789

P304

Q37600859-604FFC2D-FCB8-4475-8C7D-0C6EFE47C0E6

P31

Q37600859-56D96079-64C1-4D97-8B4A-4F8640C52AFA

P356

Q37600859-8FBED661-4BBB-4C23-8FA8-C3DD00308E9A

P433

Q37600859-3C6D9FDC-61B1-4EA5-B3EC-720573EF49E6

P478

Q37600859-7E39D63D-E6F6-4861-81FB-020DD1102A98

P50

Q37600859-D2619108-69E9-450C-991C-F79ACAC6B3A4

P577

Q37600859-EE7650D8-E817-419C-9661-9A3583FC397F

P698

Q37600859-4157832B-7519-49D5-835C-BD3C905A9155

P921

Q37600859-22EAAB63-ACB1-4F48-85A1-BC56854DC9C8

P356

P1433

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

P1476

Guillain-Barré syndrome: update on immunobiology and treatment.

@en

P2093

Kenichi Kaida

http://www.w3.org/2001/XMLSchema#string

P2860

Immunotherapy for Guillain-Barre syndrome: a systematic review

Guillain-Barré syndrome

Structure of and influence of a tick complement inhibitor on human complement component 5

Lipid rafts and signal transduction

Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria

Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations.

Cell adhesion/recognition and signal transduction through glycosphingolipid microdomain.

Complement-targeted therapeutics

Paralytic shellfish poisoning: a case report and serial electrophysiologic observations.

The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria.

P304

1307-1319

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERN.09.77

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Susumu Kusunoki

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19769446

http://www.w3.org/2001/XMLSchema#string

P921

Guillain–Barré Syndrome